home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Mastering Medicinal Chemistry

 
  February 11, 2014  
     
 
Westin Boston Waterfront, Boston, MA, USA
May 21-22, 2014


After more than a decade at the Moscone Convention Center in San Francisco, the successful Mastering Medicinal Chemistry conference is moving to the East Coast. As the must-attend event for senior medicinal chemists, we invite you to join us at our new location in Boston, MA!

Senior executives and industry thought leaders from Pfizer, Roche, Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, AbbVie, AstraZeneca and many more will participate in this year’s program with inspiring discussions on the future role of medicinal chemistry and its contribution to improved drug discovery rates. Senior level chemists from leading life science companies will also discuss how kinetics and residence time, targeted tissue delivery, and allosteric inhibitors enhance profiles or modulate difficult targets. Network and share case studies on difficult targets with industry leading chemists and senior thought leaders during panel discussions, guided roundtable discussions and dedicated exhibit hall hours.
 
 
Organized by: Cambridge Healthtech Institute (CHI)
Invited Speakers:
  • Eddine Saiah, Ph.D., Atlas Venture
  • Hans-Joachim Boehm, Ph.D., Global Head, Small Molecule Research, Roche
  • Mark Bunnage, D.Phil., Vice President, Head, Chemistry, Biotherapeutics Research, Pfizer, Inc.
  • Mike Hann, Ph.D., Director, Chemical Sciences, R&D Platform Technology & Sciences, GlaxoSmithKline
  • Jorg Holenz, Ph.D., Director, Discovery & Preclinical Sciences, AstraZeneca Pharmaceuticals
  • Fabrizio Giordanetto, Ph.D., Director, Medicinal Chemistry, Taros Chemicals GmbH & Co. KG
  • Stuart Onions, Ph.D., Director, Research Management, Sygnature Discovery Ltd
  • Peter Hamley, Ph.D., Global Head, Parallel Synthesis and Natural Products, Sanofi-Aventis
  • Suvit Thaisrivongs, Ph.D., Head, Immunoscience Research Unit Chemistry, Worldwide Medicinal Chemistry, Pfizer, Inc.
  • Woody Sherman, Ph.D., Vice President, Applications Science, Schrödinger, Inc.
  • Stewart L. Fisher, Ph.D., Principal, SL Fisher Consulting, LLC
  • John Mathias, Ph.D., Senior Director & Head, Medicinal Chemistry, Inflammation & Remodeling, Pfizer, Inc.
  • Christopher J. O’Donnell, Ph.D., Senior Director, Oncology Medicinal Chemistry, Pfizer, Inc.
  • Patrick Beusker, Ph.D., Director, Antibody-Drug Conjugates, Synthon
  • Roman Kombarov, Ph.D., Project Manager, ASINEX
  • Chris Williams, Ph.D., Principal Scientist, Chemical Computing Group
  • Craig W. Lindsley, Ph.D., Director, Medicinal Chemistry, Vanderbilt University Medical Center
  • Chantal Alcouffe, Medicinal Chemistry Team Leader, Early to Candidate, Sanofi
  • Patrick Beusker, Ph.D., Director Antibody-Drug Conjugates, Synthon
  • Renato Skerlj, Ph.D., Founder, Drug Discovery Consulting LLC; former Head, Small Molecule Discovery, Genzyme, a sanofi company
  • W. Patrick Walters, Ph.D., Principal Research Fellow, Group Head, Computational Sciences, Vertex Pharmaceuticals, Inc.
  • Anthony Nicholls, Ph.D., CEO & Founder, OpenEye Scientific Software
  • Peter J. Tonge, Ph.D., Professor, Chemistry, Institute for Chemical Biology & Drug Discovery, Stony Brook University
  • Rick Roberts, Ph.D., Senior Scientist, Medicinal Chemistry, Almirall
  • P. Ann Boriack-Sjodin, Ph.D., Director, Protein and Structural Sciences, Epizyme, Inc.
  • Vincent S. Stoll, Ph.D., Associate Director, Structural Biology, AbbVie
  • Kap-Sun Yeung, Ph.D., Principal Scientist, Discovery Chemistry, Bristol-Myers Squibb
 
Deadline for Abstracts: ---
 
Registration: Register now
E-mail: kwaterman@healthtech.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.